Inozyme Pharma, Inc. is a rare disease biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. It is focused on develop... Read more
CNBC
MarketWatch
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.